Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Repair of a Nasal Ala Defect.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]·2026
Same author

Topical Sodium Thiosulfate for the Treatment of Calciphylaxis: Case Report.

Nephrology (Carlton, Vic.)·2026
Same author

Electroencephalogram Monitoring in Critical Care: Multicenter Analysis of Timing, Duration, and Readmissions.

Critical care explorations·2026
Same author

Social determinants of health as risk and protective factors for health care access among sexual and gender minority parents.

Scientific reports·2026
Same author

Medicaid Home and Community-Based Services Initiation and Acute Services Use.

JAMA health forum·2026
Same author

Distinct Inflammatory Profiles in Angiography-Negative Subarachnoid Hemorrhage: A Focused Case Series.

medRxiv : the preprint server for health sciences·2026

Related Experiment Video

Updated: Jul 18, 2026

Cerenkov Luminescence Imaging CLI for Cancer Therapy Monitoring
08:45

Cerenkov Luminescence Imaging CLI for Cancer Therapy Monitoring

Published on: November 13, 2012

13.7K

Cancer Survivorship at Stanford Cancer Institute.

Stephanie M Smith1, Natasha Steele2, Jennifer Kim3

  • 1Department of Pediatrics, Division of Hematology, Oncology, Stem Cell Transplantation and Regenerative Medicine, Stanford University School of Medicine, Stanford, USA.

Journal of Cancer Survivorship : Research and Practice
|January 6, 2024
PubMed
Summary

Stanford

Keywords:
Care deliveryEducationEquityMental healthPrimary care

More Related Videos

Methods for Culturing Human Femur Tissue Explants to Study Breast Cancer Cell Colonization of the Metastatic Niche
11:41

Methods for Culturing Human Femur Tissue Explants to Study Breast Cancer Cell Colonization of the Metastatic Niche

Published on: March 15, 2015

12.5K
Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model
07:49

Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model

Published on: April 13, 2015

20.1K

Related Experiment Videos

Last Updated: Jul 18, 2026

Cerenkov Luminescence Imaging CLI for Cancer Therapy Monitoring
08:45

Cerenkov Luminescence Imaging CLI for Cancer Therapy Monitoring

Published on: November 13, 2012

13.7K
Methods for Culturing Human Femur Tissue Explants to Study Breast Cancer Cell Colonization of the Metastatic Niche
11:41

Methods for Culturing Human Femur Tissue Explants to Study Breast Cancer Cell Colonization of the Metastatic Niche

Published on: March 15, 2015

12.5K
Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model
07:49

Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model

Published on: April 13, 2015

20.1K

Area of Science:

  • Oncology
  • Cancer Survivorship
  • Public Health

Background:

  • The Stanford Cancer Survivorship Program addresses the comprehensive needs of cancer patients and their families.
  • It focuses on improving patient and caregiver experiences and outcomes across the cancer continuum.

Purpose of the Study:

  • To outline the mission, structure, and key initiatives of the Stanford Cancer Survivorship Program.
  • To highlight advancements in research, clinical care, education, and community engagement for cancer survivors.

Main Methods:

  • The program integrates clinical care, professional education, patient-oriented research, and community engagement.
  • Key areas include adolescents and young adults (AYAs), mental health, primary care integration, and postgraduate medical education.
  • Clinical care models feature embedded clinics, novel specialty services, and primary care-based clinics.

Main Results:

  • Educational initiatives include online courses, textbooks, lectures, and trainee rotations.
  • Patient-facing activities involve webinars and podcasts for information dissemination.
  • Research explores oncofertility, AYA communication, digital interventions for quality of life, and community partnerships.

Conclusions:

  • Stanford's Cancer Survivorship Program offers a comprehensive platform for research, training, and clinical care.
  • The program is dedicated to enhancing access and improving care for individuals living with and beyond cancer through innovative approaches.